SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Eargo, Inc. EAR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Eargo, Inc. (EAR) is a Medical - Devices company in the Healthcare sector, currently trading at $2.57. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $37M, +24.4%/yr average growth. Net income is $157M (loss), growing at -131%/yr. Net profit margin is -422.8% (negative). Gross margin is 38.3% (-13.5 pp trend).

Balance sheet: total debt is $7M against $101M equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 4.6 (strong liquidity). Debt-to-assets is 5%. Total assets: $132M.

Analyst outlook: 0 / 3 analysts rate EAR as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 21/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).

EAR SharesGrow Score Overview

35/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 21/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — EAR

No analyst coverage available for this stock.

EAR: +24.4%/yr revenue is, -131%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet EAR: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 4.6 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

EAR: Gross margin is 38.3% (-13.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 3 analysts rate EAR as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

EAR: Net profit margin is -422.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range1.465-8.48

Volume201.27K

Avg Volume (30D)26.89K

Market Cap$53.36M

Beta (1Y)1.48

Share Statistics

EPS (TTM)-39.68

Shares Outstanding$3.97M

IPO Date2020-10-16

Employees243

CEOWilliam H. Brownie

Financial Highlights & Ratios

Revenue (TTM)$37.25M

Gross Profit$14.26M

EBITDA$-156.07M

Net Income$-157.49M

Operating Income$-111.76M

Total Cash$101.24M

Total Debt$6.6M

Net Debt$-94.64M

Total Assets$132.08M

Price / Earnings (P/E)-0.1

Price / Sales (P/S)1.43

Analyst Forecast

Rating ConsensusHold

Analysts Covering3

Buy 0% Hold 67% Sell 33%

Company Info

CountryUS

ExchangeNASDAQ Global Select

CurrencyUSD

ISINUS2700872086

Price Chart

EAR

Eargo, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Devices

1.47 52WK RANGE 8.48

People Also View

Heska Corporation

Surmodics, Inc.

NeuroPace, Inc.

Orthofix Medical Inc.

OrthoPediatrics Corp.

Anika Therapeutics, Inc.

Electromed, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message